Epitome Therapeutics raises $4.3M Pre-seed (Austria, Jun 2026)
Reach the investors backing rounds like this
Backed by XISTA Science Ventures, Caesar Ventures +1 more · verified emails and LinkedIn on Datapile
Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team - EU-Startups
Epitome Therapeutics is a BioTech company focused on advancing precision epigenome editing for programmable gene expression. The company aims to develop new therapeutic approaches based on the precise regulation of gene expression, with a notable emphasis on their CADENCE platform. This funding will help them build their team and advance their development programmes.
Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team EU-Startups
| Jun 24, 2026 | Ora Computing | $3.7M | Seed | Austria |
| Jun 18, 2026 | SOMAREALITY | $3.2M | Series A | Austria |
| Jun 11, 2026 | Fonio.ai | $17.0M | Seed | Austria |
| Jun 09, 2026 | Invisible-Light Labs | $1.6M | — | Austria |
1,134 investors back startups in Austria
You just read who funded Epitome Therapeutics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.